[New antihyperglycemic drugs. Examination of cardiovascular outcomes with alogliptin versus standard of care (EXAMINE) and saxagliptin assessment of vascular outcomes recorded in patients with diabetes mellitus-thrombolysis in myocardial infarction (SAVOR-TIMI 53)]. / Neue antihyperglykämische Therapeutika. Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care (EXAMINE) und Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus-Thrombolysis in Myocardial Infarction (SAVOR-TIMI 53).
Internist (Berl)
; 55(7): 859-62, 2014 Jul.
Article
en De
| MEDLINE
| ID: mdl-24969610
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Piperidinas
/
Uracilo
/
Adamantano
/
Enfermedades Cardiovasculares
/
Diabetes Mellitus Tipo 2
/
Dipéptidos
/
Inhibidores de la Dipeptidil-Peptidasa IV
/
Hipoglucemiantes
/
Angina Inestable
/
Infarto del Miocardio
Límite:
Female
/
Humans
/
Male
Idioma:
De
Revista:
Internist (Berl)
Año:
2014
Tipo del documento:
Article
Pais de publicación:
Alemania